Transradial versus transfemoral coronary intervention for acute myocardial infarction complicated by cardiogenic shock: Is transradial coronary intervention suitable for emergency PCI in high-risk acute myocardial infarction?

Journal of Invasive Cardiology

Volumn 26, Issue 5, 2014, Pages 196-202

  Iga, Atsushi ^a   Wagatsuma, Kenji ^b   Yamazaki, Junichi ^a   Ikeda, Takanori ^a  

^a TOHO UNIVERSITY   (Japan)

^b Tsukuba Memorial Hospital   (Japan)

Author keywords

Bleeding; Cardiogenic shock; STEMI

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CORONARY ARTERY COLLATERAL CIRCULATION; EMERGENCY CARE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; TRANSFEMORAL CORONARY INTERVENTION; TRANSRADIAL CORONARY INTERVENTION; VASCULAR ACCESS; COMPARATIVE STUDY; COMPLICATION; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; FEMORAL ARTERY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROCEDURES; RADIAL ARTERY; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME TO TREATMENT; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; RADIAL ARTERY; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84899861201     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial in-farction: Quantitative review of 23 randomized trials. Lancet.2003;361(9351):13-20
2. Kiemeneij F, Laarman G. Percutaneous transradial artery ap-proach for coronary stent implantation. Cathet Cardiovasc Di-Agn.1993;30(2):173-178
3. Shibata Y, Doi O, Goto T, et al. New guiding catheter for tran-sradial percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn.1998;43(3):344-351
4. Yang CH, Guo BF, Yip HK, et al. Bilateral cardiac catheteriza-Tions; The safety and feasibility of superficial forearm venous and transradial arterial approach. Int Heart J.2006;47(1):21-27
5. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-Analysis of randomized trials.J Am Coll Cardiol.2004;44(2):349-356
6. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on ma-jor bleeding and ischemic events: A systematic review and meta-Analysis of randomized trials. Am Heart J.2009;157(1):132-140
7. Doyle BJ, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: In-cidence, predictors, and impact on long-Term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.JACC Cardiovasc Interv.2008;1(2):202-209
8. Elbarouni B, Elmanfud O, Yan RT, et al. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J.2010;160(3):420-427
9. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syn-dromes. Am J Cardiol.2005;96(9):1200-1206
10. EikeIboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patietns with acute coronary syn-dromes. Circulation.2006;114(8): 774-782
11. Manoukian SV, Feit F, Mehran R, et a.l. Impact of major bleeding on 30-day mortality and clinical outcomes in patietns with acute coronary syndromes; an analysis from the ACUITY trial.J Am Coll Cardiol.2007;49(12):1362- 1368
12. .Stone GW. Ischaemia versus bleeding: The art of clinical decision-making. Lancet.2009;373(9665):695-696
13. Rao SV. Strategies to reduce bleeding among patients with isch-emic heart disease treated with antiplatelet therapies. Am J Car-diol.2009;104(5 Suppl):60C-63C.
14. Jeger RV, Radovanovic D, Hunziker PR, et al; AMIS Plus Regis-Try Investigators. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med.2008;149(9):618-626
15. Webb JG, Sanborn TA, Sleeper LA, et al; SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J.2001;141(6):964-970
16. Babaev A, Frederick PD, Pasta DJ, et al; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA.2005;294(4):448-454
17. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock.N Engl J Med.1999;341(9):625-634
18. Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospi-Tal death rates associated with cardiogenic shock in patients with acute myocardial infarction: A popuration-based perspective. Cir-culation.2009;119(9):1211-1219
19. Dauerman HL, Goldberg RJ, White K, et al; Global Registry of Acute Coronary Events. GRACE Investigators. Revasculariza-Tion, stenting, and outcomes of patients with acute myocar-dial infaction complicated by cardiogenic shock. Am J Cardiol.2002;90(8):838-842
20. Drakos SG, Bonios MJ, Anastasiou-Nana MI, et al. Long-Term survival and outcomes after hospitaliazation for acute myocar-dial infarction complicated by cardiogenic shock. Clin Cardiol.2009;32(8):E4-E8
21. .Lekston A, Slonka G, Gasior M, et al. Comparison of early and long-Term results of percutaneous coronary interventions in pa-Tients with ST elevation myocardial infarction, complicated or not by cardiogenic shock. Coron Artery Dis.2010;21(1):13-19
22. Jolly SS, Yusuf S, Cairns J, et al; RIVAL trial group. Radial ver-sus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomized, parallel group, multicenter trial. Lancet.2011;377(9775):1409-1420
23. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et a.l. Radial ver-sus femoral randomized investigation in ST-segment elevation acute coronary syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Cor-onary Syndrome) study.J Am Coll Cardiol.2012;60(24):2481-2489
24. Vorobcsuk A, Kónyi A, Aradi D, et al. Transradial versus trans-femoral percutaneous coronary intervention in acute myocardi-Al infarction: Systematic overview and meta-Analysis. Am Heart J.2009;158(5):814- 821
25. Bertrand OF, Bélisle P, Joyal D, et al. Comparison of transra-dial and femoral approaches for percutaneous coronary inter-ventions: A systematic review and hierarchical Bayesian meta-Analysis. Am Heart J.2012;163(4):632-648
26. O'Connor RE, Brady W, Brooks SC, et al. Part 10: Acute coronary syndromes: 2010 American Heart Association guidelines for cardiopulmonary resucitation and emer-gency cardiovascular care. Circulation.2010;122(18 Suppl 3):S787-S817
27. Marcolino MS, Simsek C, de Boer SP, et al. Short- And long-Term major adverse car-diac events in patients undergoing percutaneous coronary intervention with stent-ing for acute myocarial infarction complicated by cardiogenic shock. Cardiology.2012;121(1):47-55
28. Hetherington SL, Adam Z, Morley R, et al. Primary percutaneous coronary inter-vention for acute ST-segment elevation myocardial infarction: Changing patterns of vascular access, radial versus femoral artery. Heart.2009;95(19): 1612-1618
29. Suh JW, Mehran R, Claessen BE, et al. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction: The HORIZONS-AMI (Harmonizing Outcomes With Re-vascularization and Stents in Acute Myocardial Infarction) trial.J Am Coll Cardiol.2011;58(17):1750-1756
30. Costa MA, Carere RG, Lichtenstein SV, et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).Circulation. 2001;104(22):2689-2693
31. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coro-nary syndromes: The Global Registry of Acute Coronary Events (GRACE).Eur Heart J.2003;24(20):1815-1823
32. Mehran R, Pocock SJ, Stone GW, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non- ST elevation acute coronary syndromes: A risk model from the ACUITY trial. Eur Heart J.2009;30(12):1457-1466
33. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral ap-proach for percutaneous coronary diagnostic and interventional procedures; sys-Tematic overview and meta-Analysis of randomaized trials.J Am Coll Cardiol.2004;44(2):349-356
34. Généreux P, Mehran R, Palmerini T, et al; HORIZONS-AMI Trial Investigators. Radial access in patients with ST-segment elevation myocardial infarction undergo-ing primary angioplasty in acute myocardial infarction: The HORIZONS-AMI trial. EuroIntervention.2011;7(8):905-916
35. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-Aortic balloon support with a percutaneous left ventricular assist device in patients with revascu-larized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J.2005;26(13):1276-1283
36. Thiele H, Allam B, Chatellier G, et a.l. Shock in acute myocardial infarction: The Cape Horn for trials?. Eur Heart J.2010;31(15):1828-1835
37. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA.2004;292(13):1555-1562
38. Van De Werf F, Bax J, Betriu A, et al; ESC Committee for Practice Guidelines (CPG).Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J.2008;29(23):2909-2945
39. Antman EM, Anbe DT, Armstrong PW, et al; American College of Cardiology/Amer-ican Heart Association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: Executive summary. Circulation.2004;110(5):588-636
40. Bahekar A, Singh M, Singh S, et a.l. Cardiovascular outcomes using intra-Aortic bal-loon pump in high-risk acute myocardial infarction with or without cardiogenic shock: A meta-Analysis.J Cardiovasc Pharm Ther.2012;17(1):44-56
41. Morisawa D, Higuchi Y, Iwakura K, et a.l. Predictive factors for successful weaning from percutaneous cardiopulmonary support in patients with cardiogenic shock com-plicating acute myocardial infarction.J Cardiol.2012;60(5):350-354
42. Jollis JG, Roettig ML, Aluko AO, et al; Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) Investigators. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA.2007;298(20):2371-2380
43. Katz JN, Stebbins AL, Alexander JH, et al; TRIUMPH Investigators. Predictors of 30- day mortality in patients with refractory cardiogenic shock following acute myocardial infarction Despite a patent infarct artery. Am Heart J.2009;158(4):680-687
44. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv.2008;1(4):379-386
45. Terkelsen CJ, Sørensen JT, Maeng M, et al. System delay and mortality among pa-Tients with STEMI treated with primary percutaneous coronary intervention. JAMA.2010;304(7):763-771
46. Vink MA, Amoroso G, Dirksen MT, et al. Routine use of the transradial approach in primary percutaneous coronary intervention: Procedural aspects and outcomes in 2209 patients treated in a single high-volume centre. Heart.2011;97(23):1938- 1942
47. Cooper CJ, El-Shiekh RA, Cohen DJ, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J.1999;138(3 Pt 1):430-436
48. Mann JT 3rd, Cubeddu MG, Schneider JE, et al. Right radial access for PTCA: A prospective study demonstrates reduced complications and hospital charges.J Invasive Cardiol.1996;8(Suppl D):40D-44D..